Cargando…

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis

Progressive impairment in lung function caused by chronic polymicrobial airway infection remains the major cause of death in patients with cystic fibrosis (CF). Cross-sectional studies suggest an association between lung function decline and specific lung microbiome ecotypes. However, longitudinal s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metzger, Marisa I., Graeber, Simon Y., Stahl, Mirjam, Sommerburg, Olaf, Mall, Marcus A., Dalpke, Alexander H., Boutin, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687143/ https://www.ncbi.nlm.nih.gov/pubmed/34938669 http://dx.doi.org/10.3389/fcimb.2021.763121

Ejemplares similares

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
por: Yi, Buqing, et al.
Publicado: (2021)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
por: Frey, Dario L., et al.
Publicado: (2022)

Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation
por: Tony-Odigie, Andrew, et al.
Publicado: (2022)

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2017)

Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2015)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
por: Berges, Julian, et al.
Publicado: (2023)

Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
por: Hahn, Andrea, et al.
Publicado: (2020)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
por: Steinke, Eva, et al.
Publicado: (2023)

The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi
por: de Almeida, Otávio Guilherme Gonçalves, et al.
Publicado: (2020)

Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients
por: Boutin, Sébastien, et al.
Publicado: (2017)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
por: Wucherpfennig, Lena, et al.
Publicado: (2023)

Increased Inflammatory Markers Detected in Nasal Lavage Correlate with Paranasal Sinus Abnormalities at MRI in Adolescent Patients with Cystic Fibrosis
por: Chung, Jaehi, et al.
Publicado: (2021)

Synergy Between Pseudomonas aeruginosa Filtrates And Voriconazole Against Aspergillus fumigatus Biofilm Is Less for Mucoid Isolates From Persons With Cystic Fibrosis
por: Sass, Gabriele, et al.
Publicado: (2022)

Bacterial Subversion of Autophagy in Cystic Fibrosis
por: Flores-Vega, Verónica Roxana, et al.
Publicado: (2021)

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis
por: Leutz-Schmidt, Patricia, et al.
Publicado: (2023)

Editorial: Fungal Respiratory Infections in Cystic Fibrosis
por: Papon, Nicolas, et al.
Publicado: (2021)

Editorial: Co-Infection and Consequences in Cystic Fibrosis
por: Kahl, Barbara C., et al.
Publicado: (2022)

Supplementation with Red Palm Oil Increases β-Carotene and Vitamin A Blood Levels in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2015)

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis
por: Stahl, Mirjam, et al.
Publicado: (2021)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
por: Piehler, Linus, et al.
Publicado: (2023)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2021)

Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review
por: Bonnet, Pierre, et al.
Publicado: (2020)

Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis
por: Biswas, Lalitha, et al.
Publicado: (2022)

Inquilinus limosus in Patients with Cystic Fibrosis, Germany
por: Wellinghausen, Nele, et al.
Publicado: (2005)

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2021)

Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses
por: Sommerburg, Olaf, et al.
Publicado: (2020)

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019)

ELISA Test for the Serological Detection of Scedosporium/Lomentospora in Cystic Fibrosis Patients
por: Martin-Souto, Leire, et al.
Publicado: (2020)

An Innovative Protocol for Metaproteomic Analyses of Microbial Pathogens in Cystic Fibrosis Sputum
por: Graf, Alexander C., et al.
Publicado: (2021)

Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs
por: Einarsson, Gisli G., et al.
Publicado: (2022)

Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
por: Grehn, Claudia, et al.
Publicado: (2021)

Prospective Evaluation of Aspergillus fumigatus-Specific IgG in Patients With Cystic Fibrosis
por: Eschenhagen, Patience, et al.
Publicado: (2021)

Salivary Microbiome in Adenoid Cystic Carcinoma Detected by 16S rRNA Sequencing and Shotgun Metagenomics
por: Jiang, Qian, et al.
Publicado: (2021)

CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages
por: Badr, Asmaa, et al.
Publicado: (2022)

Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis
por: O’Connor, John B., et al.
Publicado: (2022)

Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis
por: Le Goff, Mélanie, et al.
Publicado: (2022)

CFTR Modulators Dampen Aspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes
por: Currie, Alexander J., et al.
Publicado: (2020)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
por: Acosta, Nicole, et al.
Publicado: (2020)

Adaptive Immune Response to Mycobacterium abscessus Complex (MABSC) in Cystic Fibrosis and the Implications of Cross-Reactivity
por: Mauch, Renan Marrichi, et al.
Publicado: (2022)

Comparative Analysis of Clinical Parameters and Sputum Biomarkers in Establishing the Relevance of Filamentous Fungi in Cystic Fibrosis
por: Patel, Deepa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9759eu2ni1lqic7es9utvnggt0